Ginkgo bioworks announces acquisition of agbiome's platform assets

Boston , april 11, 2024 /prnewswire/ -- today, ginkgo bioworks (nyse: dna ), which is building the leading platform for cell programming and biosecurity, announced the acquisition of agbiome's platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as agbiome's development pipeline. these assets will be integrated into ginkgo ag biologicals services , established with the acquisition  of a bayer agricultural biologicals r&d facility in 2022, and will expand ginkgo's proprietary unified metagenomics database.
DNA Ratings Summary
DNA Quant Ranking